Wang; Shanchun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Shanchun.The latest application filed is for "methyl- and trifluoromethyl-containing disubstituted sulfonamide selective bcl-2 inhibitor".

Company Profile

15.9.19

Wang; Shanchun - Jiangsu CN
WANG; Shanchun - Lianyungang City CN
WANG; Shanchun - Lianyungang CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinoline derivative for treatment of nasopharyngeal carcinoma Grant 11,419,862 - Wang , et al. August 23, 2	2022-08-23
Methyl- And Trifluoromethyl-containing Disubstituted Sulfonamide Selective Bcl-2 Inhibitor App 20220220110 - LIU; Fei ; et al.	2022-07-14
Quinoline Derivatives For Treatment Of Head And Neck Cancer App 20220211694 - WANG; Shanchun ; et al.	2022-07-07
Combined Pharmaceutical Composition For Treating Small Cell Lung Cancer App 20220175759 - WANG; Shanchun ; et al.	2022-06-09
Crystals Of Quinolone Derivatives App 20220098172 - ZHANG; Xiquan ; et al.	2022-03-31
Quinoline Derivative Used For Treating Small Cell Lung Cancer App 20220031689 - WANG; Shanchun ; et al.	2022-02-03
Trifluoromethyl-substituted Sulfonamide As Bcl-2-selective Inhibitor App 20220002290 - Liu; Fei ; et al.	2022-01-06
Iridinesulfonamide compound and use method thereof Grant 11,203,586 - Zhu , et al. December 21, 2	2021-12-21
Sultam compound and application method thereof Grant 11,111,240 - Zhu , et al. September 7, 2	2021-09-07
Iridinesulfonamide Compound And Use Method Thereof App 20210155610 - ZHU; Li ; et al.	2021-05-27
Sultam Compound And Application Method Thereof App 20210047314 - ZHU; Li ; et al.	2021-02-18
Quinoline derivatives for non-small cell lung cancer Grant 10,888,559 - Wang , et al. January 12, 2	2021-01-12
Quinoline Derivative For Treatment Of Triple-negative Breast Cancer App 20200405709 - TIAN; Xin ; et al.	2020-12-31
Inhaled Preparation Of Isoglycyrrhizic Acid Or Salt Thereof, And Use In Preparing Drugs For Treating Respiratory System Diseases App 20200368158 - GU; Hongmei ; et al.	2020-11-26
Quinoline Derivative For Treatment Of Nasopharyngeal Carcinoma App 20200352932 - WANG; Shanchun ; et al.	2020-11-12
Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor Grant 10,829,492 - Zhu , et al. November 10, 2	2020-11-10
Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof Grant 10,570,141 - Wang , et al. Feb	2020-02-25
Pyrrolopyrimidine compound Grant 10,561,657 - Zhu , et al. Feb	2020-02-18
Amino Pyrazolopyrimidine Compound Used As Neurotrophic Factor Tyrosine Kinase Receptor Inhibitor App 20190352306 - ZHU; Li ; et al.	2019-11-21
Substituted Pyrrolopyrimidine Cdk Inhibitor, Pharmaceutical Composition Containing Same And Use Thereof App 20190300533 - Wang; Shulong ; et al.	2019-10-03
Quinoline Derivatives For Non - Small Cell Lung Cancer App 20190298712 - Wang; Xunqiang ; et al.	2019-10-03
Method For Treating Tumour, Pharmaceutical Composition And Medicinal Kit App 20190269671 - Wang; Shanchun ; et al.	2019-09-05
Pyrrolopyrimidine Compound App 20190201403 - Zhu; Li ; et al.	2019-07-04
Quinoline derivative against non-small cell lung cancer Grant 10,307,412 - Wang , et al.	2019-06-04
Inhaled Preparation Of Isoglycyrrhizic Acid Or Salt Thereof, And Use In Preparing Drugs For Treating Respiratory System Diseases App 20190117568 - GU; Hongmei ; et al.	2019-04-25
Method for treating tumour, pharmaceutical composition and medicinal kit Grant 10,251,876 - Wang , et al.	2019-04-09
Quinoline Derivative Against Non-small Cell Lung Cancer App 20170304290 - Wang; Xunqiang ; et al.	2017-10-26
Method For Treating Tumour, Pharmaceutical Composition And Medicinal Kit App 20170182027 - Wang; Shanchun	2017-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.